Phase 1/2 Study of TAK-850 Intramuscular Injection in Healthy Pediatric Participants
Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and immunogenicity of an intramuscular
injection of TAK-850 in healthy pediatric Japanese participants.